World Journal of Otorhinolaryngology-Head and Neck Surgery (Jun 2022)

Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions

  • Sara Yang,
  • William Adams,
  • Carol Bier‐Laning

DOI
https://doi.org/10.1002/wjo2.56
Journal volume & issue
Vol. 8, no. 2
pp. 158 – 166

Abstract

Read online

Abstract Objective Unplanned 30‐day readmissions result in increased costs and decreased patient satisfaction. The objective of this study was to compare readmission rates before and after a multidisciplinary quality improvement initiative that focuses on patient and staff education, use of targeted skilled nursing facilities, and appropriate use of patient observation status. Methods This was a quality improvement study of all unplanned admissions to the Head and Neck Oncology service at a tertiary care facility during a 3‐year period between October 2015 and September 2018. In October 2016, when the Head and Neck Oncology service revised its discharge practices for patients undergoing extirpative and/or reconstructive surgery. These changes included enhancing patient education, increasing the use of a skilled nursing facility with directed staff education and patient handoffs by advanced practice nurses, and appropriate utilization of 23‐h observation status for returning patients. The readmission rate from the pre‐intervention era (October 2015 through September 2016) was compared to the readmission rate from the post‐intervention era (October 2016 through September 2018). Secondary outcomes were the rates of 23‐h observation within 30 days of the discharge as well as emergency room visits within 30 days of discharge. Results In this sample of 449 patients, 161 (35.9%) were observed before the change‐in‐practice (before October 2016), and 288 (64.1%) were observed following the change‐in‐practice (after September 2016). On univariable analysis, the risk of readmission declined by approximately 41.4% from the pre‐intervention era, though this conclusion was not statistically significant (P = 0.06). On multivariable analysis, patients at moderate or high risk of death were 2.31 times more likely than those at minor risk of death to readmit within 30 days (P = 0.03). Similarly, those with recurrent or persistent cancer were 3.33 times more likely than those undergoing initial curative surgical management of cancer to readmit within 30 days (P = 0.001). No patient characteristics were associated with a 23‐h observation following discharge (all P > 0.05). Conclusions were similar for emergency room visits following discharge. Conclusions A three‐part quality improvement strategy resulted in a clinically important decrease in 30‐day readmissions, though the decline was not statistically significant. There were no significant changes in 23‐h observation within 30 days of discharge or emergency room visits within 30 days of discharge.

Keywords